Table 1 Clinical-pathological data of sarcomas’ patients
Variable | n | % |
|---|---|---|
Age | ||
>51 | 48 | 56.5 |
≤51 | 37 | 43.5 |
Gender | ||
Female | 33 | 38.8 |
Male | 52 | 61.2 |
Race | ||
Caucasian | 63 | 74.1 |
Not Caucasian | 22 | 25.9 |
Local | ||
Lower extremities | 63 | 73.3 |
Upper extremities | 23 | 26.7 |
Diagnostic | ||
Pleomorphic leiomyosarcoma | 17 | 19.8 |
Myxoid/round cells liposarcoma | 14 | 16.3 |
High grade undifferentiated pleomorphic sarcoma | 12 | 14.0 |
Monophasic fibrous synovial sarcoma | 9 | 10.5 |
Myxofibrosarcoma | 7 | 8.1 |
Malignant peripheral nerve sheath tumor | 7 | 8.1 |
Low grade fibromyxoid sarcoma | 3 | 3.5 |
Poorly differentiated synovial sarcoma | 2 | 2.3 |
High grade myofibroblastic sarcoma | 2 | 2.3 |
Clear cell sarcoma | 1 | 1.2 |
Biphasic synovial sarcoma | 1 | 1.2 |
Fibrosarcoma | 1 | 1.2 |
Angiomatoid histiocytoma | 1 | 1.2 |
Infantile fibrosarcoma | 1 | 1.2 |
Well differentiated liposarcoma | 1 | 1.2 |
Undifferentiated liposarcoma | 1 | 1.2 |
Pleomorphic liposarcoma | 1 | 1.2 |
Acral myxoinflammatory fibroblastic sarcoma | 1 | 1.2 |
Low grade myofibroblastic sarcoma | 1 | 1.2 |
Giant-cell-rich high grade undifferentiated pleomorphic sarcoma | 1 | 1.2 |
Malignant solitary fibrous tumor | 1 | 1.2 |
Alveolar sarcoma | 1 | 1.2 |
Cell lineage | ||
Fibroblastic/myofibroblastic | 28 | 32.5 |
Smooth muscle | 17 | 19.8 |
Lipogenic | 17 | 19.8 |
Peripheral nerve | 7 | 8.1 |
Miscellaneous | 17 | 19.8 |
Cellular pleomorphism | ||
Absence of pleomorphic cells | 54 | 62.8 |
Presence of pleomorphic cells | 32 | 37.2 |
Grade | ||
Low grade (I) | 30 | 32.2 |
High grade (II e III) | 63 | 67.7 |
Disease progression | ||
No | 25 | 30.9 |
Yes | 56 | 69.1 |
Disease recurrence | ||
Absent | 48 | 57.1 |
Present | 36 | 42.9 |
Metastasis | ||
Absent | 44 | 52.4 |
Present | 40 | 47.6 |